Related content

Campath 1-H treatment in patients with aggressive relapsing remitting multiple sclerosis

By Hirst C.   Pace A.   Pickersgill T.   Jones R.   McLean B.   Zajicek J.   Scolding N.   Robertson N.  

Journal of Neurology, Vol. 255, Iss. 2, 2008-02 ,pp. : 231-238

Springer Publishing Company

Access to resources Recommend Favorite

Cardiac repolarization during fingolimod treatment in patients with relapsing–remitting multiple sclerosis

By  

Brain And Behavior, Vol. 8, Iss. 2, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patients

By Zephir H.   de Seze J.   Duhamel A.   Debouverie M.   Hautecoeur P.   Lebrun C.   Malikova I.   Pelletier J.   Senechal O.   Vermersch P.  

Journal of the Neurological Sciences, Vol. 218, Iss. 1, 2004-03 ,pp. : 73-77

Elsevier

Access to resources Recommend Favorite

Optical Coherence Tomography in Patients with Relapsing-Remitting Multiple Sclerosis without Optic Neuritis: A 20-Month Longitudinal Study

By Huseyinoglu Nergiz   Ozben Serkan   Ekinci Metin   Buyukuysal Cagatay   Yıldırım Murat   Safak Hilal   Huseyin Halil  

Neuro-Ophthalmology, Vol. 37, Iss. 3, 2013-06 ,pp. : 104-110

Informa Healthcare

Access to resources Recommend Favorite

Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis

By Dong-Si T.   Weber J.   Liu Y.   Buhmann C.   Bauer H.   Bendl C.   Schnitzler P.   Grond-Ginsbach C.   Grau A.  

Journal of Neurology, Vol. 251, Iss. 5, 2004-05 ,pp. : 542-547

Springer Publishing Company

Access to resources Recommend Favorite